Clinical Trial Supply West Coast 2018
Clinical Trial Supply West Coast is returning for its 11th edition to share strategies for improving the efficiency of their clinical supply chain operations. The programme covers a broad range of topics including GMP compliance, transport management software, change control, machine learning, QP release and overcoming customs delays.
The 2018 programme offers delegates a dynamic programme of case-study presentations, interactive panel discussions and workshops and networking breaks which will enable the audience to take away practical strategies that can be used to improve the efficiency of their clinical supply chains.
2018 Agenda Highlights:
- Interactive panel: Debating the efficiencies of comparator and placebo controlled trials
- Uncovering border control requirements to ensure your trial drug reaches their destination without delays
- Using and advancing the use of Artificial Intelligence(AI) as a tool facilitating clinical trial operations and improve efficiency in clinical supply
- Assessing the use of IVRS systems for small pharma companies as an integrated platform facilitating communication and streamlining projects
- Maintaining the temperature of increasing large molecule and protein-based therapies market in the Bay area to avoid product loss and the consequent costs incurred
2018 Key Speakers:
- Karen Paese, Director, Clinical Supply Chain Management, Gilead Sciences
- Richard Horn, Director, Clinical Supplies, Nektar Therapeutics
- Robert Bottome, Executive Director, Global Supply Chain, BioMarin Pharmaceuticals
- William Goure, Chief Operating Officer, Acumen
- Louie Burks, Clinical Supply Manager, Exelixis
- John Simons, Director of Clinical Quality Assurance, Gilead Sciences
For more information, please visit: http://www.arena-international.com/ctswest?clearcache=1 or alternatively email us at: events@arena-international.com
